Stockscreener 앱 받기
22.60
0.44%
0.07
Acadia Pharmaceuticals Inc 주식(ACAD)의 최신 뉴스
Emerald Advisers LLC Sells 223,547 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Price momentum metrics for ACADIA Pharmaceuticals Inc. explainedEarnings Summary Report & Weekly Top Gainers Alerts - newser.com
Why ACADIA Pharmaceuticals Inc. stock remains undervaluedTrade Entry Summary & Fast Gaining Stock Strategy Reports - newser.com
12,050 Shares in ACADIA Pharmaceuticals Inc. $ACAD Bought by Yorktown Management & Research Co Inc - MarketBeat
ACADIA Pharmaceuticals (ACAD) to Release Quarterly Earnings on Wednesday - MarketBeat
Real time alert setup for ACADIA Pharmaceuticals Inc. performance2025 Pullback Review & Pattern Based Trade Signal System - newser.com
How ACADIA Pharmaceuticals Inc. stock performs after earnings2025 Key Highlights & Detailed Earnings Play Alerts - newser.com
ACADIA Pharmaceuticals Inc. stock trend outlook and recovery pathMarket Activity Recap & Precise Buy Zone Tips - newser.com
How sentiment analysis helps forecast ACADIA Pharmaceuticals Inc.Market Sentiment Report & Daily Profit Focused Screening - newser.com
Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
ACADIA Pharmaceuticals Advances Alzheimer’s Disease Psychosis Study with ACP-204 - TipRanks
Why ACADIA Pharmaceuticals Inc. stock appeals to dividend seekers - newser.com
Allianz Asset Management GmbH Has $369,000 Stake in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Ranking ACADIA Pharmaceuticals Inc. among high performing stocks via toolsRisk Management & Daily Growth Stock Tips - newser.com
Understanding ACADIA Pharmaceuticals Inc.’s price movementJuly 2025 Snapshot & Low Drawdown Momentum Trade Ideas - newser.com
Acadia Pharmaceuticals (NASDAQ: ACAD) to Join UBS and Jefferies Healthcare Conferences - Stock Titan
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences - Business Wire
Does Acadia (ACAD) Have the Potential to Rally 27.66% as Wall Street Analysts Expect? - sharewise.com
Is HCA HEALTHCARE (HCA) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Is ACADIA Pharmaceuticals Inc. stock a top momentum play2025 Geopolitical Influence & Long Hold Capital Preservation Plans - newser.com
How ACADIA Pharmaceuticals Inc. stock performs in high volatility marketsJuly 2025 Patterns & Reliable Volume Spike Alerts - newser.com
Is ACADIA Pharmaceuticals Inc. stock supported by strong fundamentalsMarket Risk Summary & Weekly Momentum Stock Picks - newser.com
Why ACADIA Pharmaceuticals Inc. stock is rated strong buyWeekly Volume Report & High Yield Equity Trading Tips - newser.com
ACADIA Pharmaceuticals Advances Phase 2 Study of ACP-204 for Lewy Body Dementia Psychosis - TipRanks
Is ACADIA Pharmaceuticals Inc. stock trading near support levels2025 Macro Impact & Free Daily Entry Point Trade Alerts - newser.com
Glioblastoma Multiforme Pipeline 2025: MOA and ROA Insights, - openPR.com
Glioblastoma Multiforme Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | InovioPharma, Pfizer, Roche, ACADIA Pharma, BioNTech, Oncotelic - Barchart.com
ACADIA’s ACP-204 Study: A Promising Step for Alzheimer’s Disease Psychosis Treatment - TipRanks
ACADIA Pharmaceuticals Advances Study on Carbetocin Nasal Spray for Prader-Willi Syndrome - TipRanks
ACADIA Pharmaceuticals Advances Phase 3 Study for Lewy Body Dementia Psychosis Treatment - TipRanks
Merger Talk: What catalysts could drive ACADIA Pharmaceuticals Inc. stock higherEntry Point & Fast Gaining Stock Strategy Reports - Fundação Cultural do Pará
Is ACADIA Pharmaceuticals Inc. reversing from oversold territoryEarnings Beat & Intraday High Probability Alerts - newser.com
1.30%
0.50%
자본화:
|
볼륨(24시간):